Rojo, Dionesia G.
HRN: 24-37-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2024
METRONIDAZOLE 500MG (TAB)
01/11/2024
01/14/2024
PO (PER NGT)
500mg
TID
Amoebiasis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes